On Thursday, Celgene Corporation(NASDAQ:CELG)’s shares declined -3.18% to $124.96.
Celgene Corporation (CELG) declared that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to the formerly declared tender offer by its wholly-owned partner, Strix Corporation, for all issued and outstanding shares of common stock of Receptos, Inc. (RCPT) at a price of $232.00 per share, net to the seller in cash, without interest and less required withholding taxes and subsequent merger of Strix Corporation with Receptos expired at 11:59 p.m. EDT on August 10, 2015. The expiration of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions. Celgene anticipates the transaction to close in the third quarter of 2015.
The tender offer is planned to expire at midnight EDT on Monday, August 24, 2015, unless extended.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
Comerica Incorporated(NYSE:CMA)’s shares dropped -4.19% to $44.86.
Comerica Bank and RocketSpace declared the launch of a business pitch contest focused on financial technology for the wearables market. Comerica Bank is the presenting sponsor, providing the full prize amount of $50,000 for the winning pitch.
Applications will be accepted through September 16, 2015. The five finalists will be declared on September 30th. Those finalists will compete in a “live” pitch event will be held at RocketSpace, the largest and leading technology ecosystem in the San Francisco Bay Area on October 29, 2015. The judging panel will comprise of executives from Comerica Bank’s Technology and Life Sciences Division, RocketSpace, and leading VCs. The winner will walk away with a check for $50,000.
Comerica Incorporated, through its auxiliaries, provides various financial products and services. It operates through three segments: Business Bank, Retail Bank, and Wealth Administration. The Business Bank segment offers various products and services, such as commercial loans and lines of credit, deposits, cash administration, capital market products, international trade finance, letters of credit, foreign exchange administration services, and loan syndication services to middle market businesses, multinational corporations, and governmental entities.
At the end of Thursday’s trade, Bristol-Myers Squibb Co(NYSE:BMY)‘s shares dipped -2.18% to $62.72.
Bristol-Myers Squibb Company (BMY) and Otsuka America Pharmaceutical, Inc. recently declared that the U.S. Food and Drug Administration (FDA) has approved an update to the Sprycel® (dasatinib) product labeling. The labeling now comprises five-year efficacy and safety data in adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and seven-year data in CP Ph+ CML patients who are resistant1 or intolerant2 to preceding therapy, counting Gleevec®3 (imatinib mesylate).
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Avago Technologies Ltd(NASDAQ:AVGO), ended its Thursday’s trading session with -5.29% loss, and closed at $115.03.
Avago Technologies Limited (AVGO), a leading semiconductor device supplier to the wireless, enterprise storage, wired, and industrial end markets, declared it will report its third quarter fiscal year 2015 financial results and business outlook on Wednesday, August 26, 2015 after the close of the market. Avago’s administration will host a conference call at 2:00 p.m. Pacific Time on the same day to talk about these results and business outlook.
Avago Technologies Limited designs, develops, and supplies semiconductor devices with a focus on analog III-V based products. The company operates through four segments: Wireless Communications, Wired Infrastructure, Enterprise Storage, and Industrial & Other segments. Its product portfolio comprises RF power amplifiers, RF filters, RF front end modules, ambient light sensors, proximity sensors, low noise amplifiers, multimarket-wave mixers, diodes, fiber optic transceivers, serializer/deserializer ASICs, and optical laser and receiver components.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
